Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Sala

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Frontiers in Nutrition|July 31, 2025
Exploratory study of the effect of DHA supplementation on blood fatty acids and inflammatory markers in children with MIS-CElvira Verduci, Patrizia Risè, Giulia Fiore, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 6, 2004
Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienesAntonio Di Gennaro, Chiara Carnini, Carola Buccellati, et al.
Journal of Breath Research|January 28, 2016
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokersGiuseppe Santini, Nadia Mores, Rugia Shohreh, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administrationNadia Moretto, Paola Caruso, Raffaella Bosco, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration--in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic windowGino Villetti, Chiara Carnini, Loredana Battipaglia, et al.
Journal of Medicinal Chemistry|October 22, 2025
Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-<i>b</i>]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor AntagonistsFederica Blua, Francesca Boccato, Carola Buccellati, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 30, 2023
Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in MiceMariarita Galbiati, Marco Meroni, Marina Boido, et al.
Journal of Medicinal Chemistry|August 23, 2019
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase DomainJan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.
Molecular Aspects of Medicine|September 7, 2020
The Atlas of Inflammation Resolution (AIR)Charles N Serhan, Shailendra K Gupta, Mauro Perretti, et al.
Molecular Aspects of Medicine|September 3, 2020
WITHDRAWN: The Atlas of Inflammation Resolution (AIR)Charles N Serhan, Shailendra K Gupta, Mauro Perretti, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Frontiers in Nutrition|July 31, 2025
Exploratory study of the effect of DHA supplementation on blood fatty acids and inflammatory markers in children with MIS-CElvira Verduci, Patrizia Risè, Giulia Fiore, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 6, 2004
Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienesAntonio Di Gennaro, Chiara Carnini, Carola Buccellati, et al.
Journal of Breath Research|January 28, 2016
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokersGiuseppe Santini, Nadia Mores, Rugia Shohreh, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
CHF6001 I: a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administrationNadia Moretto, Paola Caruso, Raffaella Bosco, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration--in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic windowGino Villetti, Chiara Carnini, Loredana Battipaglia, et al.
Journal of Medicinal Chemistry|October 22, 2025
Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-<i>b</i>]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor AntagonistsFederica Blua, Francesca Boccato, Carola Buccellati, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 30, 2023
Bicalutamide and Trehalose Ameliorate Spinal and Bulbar Muscular Atrophy Pathology in MiceMariarita Galbiati, Marco Meroni, Marina Boido, et al.
Journal of Medicinal Chemistry|August 23, 2019
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase DomainJan S Kramer, Stefano Woltersdorf, Thomas Duflot, et al.
Molecular Aspects of Medicine|September 7, 2020
The Atlas of Inflammation Resolution (AIR)Charles N Serhan, Shailendra K Gupta, Mauro Perretti, et al.
Molecular Aspects of Medicine|September 3, 2020
WITHDRAWN: The Atlas of Inflammation Resolution (AIR)Charles N Serhan, Shailendra K Gupta, Mauro Perretti, et al.
Pageof 6